William Plovanic Analyst PerformanceMed-Tech Operator and Investment Professional at Canaccord Genuity GroupWilliam Plovanic is a stock analyst at Canaccord Genuity Group focused in the healthcare sector, covering 32 publicly traded companies. Over the past year, William Plovanic has issued 66 stock ratings, including buy and hold recommendations. While full access to William Plovanic's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights William Plovanic's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings180 Last 11 YearsBuy Recommendations86.39% 146 Buy RatingsCompanies Covered32 Unique Companies Ratings Distribution169RatingsDistribution of strong buy, buy, hold, and sell ratings by William Plovanic.RatingPercentageCount Strong Buy0.0%0 ratings Buy86.4%146 ratings Hold13.6%23 ratings Sell0.0%0 ratingsOut of 169 total stock ratings issued by William Plovanic at Canaccord Genuity Group, the majority (86.4%) have been Buy recommendations, followed by 13.6% Hold.Best & Worst CallsBest Call0000.0%TMDXMar 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%RSLSJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ68.8% of companies on NASDAQ22 companiesNYSE28.1% of companies on NYSE9 companiesOTCMKTS3.1% of companies on OTCMKTS1 companyWilliam Plovanic, an analyst at Canaccord Genuity Group, currently covers 32 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare31 companies96.9%Technology1 company3.1%William Plovanic of Canaccord Genuity Group specializes in stock coverage within the Healthcare sector, with additional focus on Technology companies.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES28 companies87.5%BIOTECHNOLOGY2 companies6.3%HEALTHCARE TECHNOLOGY1 company3.1%ELECTROMEDICAL EQUIPMENT1 company3.1% William Plovanic's Ratings History at Canaccord Genuity Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsDXCMDexCom8/3/2026Set Price Target$86.87$90.00Buy$0.0000.00% ROIBSXBoston Scientific7/30/2026Lower Price Target$44.75$66.00Buy$0.0000.00% ROITMDXTransMedics Group6/30/2026Reiterated Rating$65.56$124.00Buy$0.0000.00% ROIAORTArtivion6/16/2026Reiterated Rating$20.98$36.00Buy$0.0000.00% ROIPLSEPulse Biosciences6/4/2026Initiated Coverage$24.99$32.00Buy$0.0000.00% ROIBSXBoston Scientific6/1/2026Lower Price Target$48.54$70.00Buy$0.0000.00% ROIIRTCiRhythm Technologies6/1/2026Lower Price Target$113.36$152.00Buy$0.0000.00% ROIDXCMDexCom5/18/2026Set Price Target$64.85$82.00Buy$0.0000.00% ROIHTFLHeartflow5/15/2026Lower Price Target$32.24$37.00Buy$0.0000.00% ROICBLLCeriBell5/12/2026Lower Price Target$20.06$25.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. PODDInsulet5/7/2026Lower Price Target$151.28$249.00Buy$0.0000.00% ROIATRCAtriCure5/6/2026Boost Price Target$28.32$55.00Buy$0.0000.00% ROITMDXTransMedics Group5/6/2026Lower Price Target$72.92$124.00Buy$0.0000.00% ROIDXCMDexCom5/1/2026Set Price Target$59.55$100.00Buy$0.0000.00% ROIIRTCiRhythm Technologies5/1/2026Lower Price Target$120.80$180.00Buy$0.0000.00% ROIEWEdwards Lifesciences4/24/2026Set Price Target$83.25$85.00Hold$0.0000.00% ROIBSXBoston Scientific4/23/2026Lower Price Target$65.78$71.00Buy$0.0000.00% ROICVRXCVRx4/14/2026Reiterated Rating$8.00$10.00Buy$0.0000.00% ROIHTFLHeartflow3/19/2026Boost Price Target$25.03$43.00Buy$0.0000.00% ROISTIMNeuronetics3/19/2026Lower Price Target$1.43$3.00Buy$0.0000.00% ROIHTFLHeartflow3/9/2026Reiterated Rating$23.30$40.00Buy$0.0000.00% ROITLSITriSalus Life Sciences3/6/2026Lower Price Target$4.44$7.00Buy$0.0000.00% ROIIRTCiRhythm Technologies2/20/2026Lower Price Target$150.48$198.00Buy$0.0000.00% ROIATRCAtriCure2/18/2026Lower Price Target$31.32$53.00Buy$0.0000.00% ROIBSXBoston Scientific2/17/2026Lower Price Target$76.28$109.00Buy$0.0000.00% ROIDXCMDexCom2/13/2026Set Price Target$70.54$95.00Buy$0.0000.00% ROICVRXCVRx2/13/2026Lower Price Target$5.69$10.00Buy$0.0000.00% ROIAORTArtivion2/13/2026Lower Price Target$35.51$48.00Buy$0.0000.00% ROIBSXBoston Scientific2/5/2026Lower Price Target$75.50$112.00Buy$0.0000.00% ROISIBNSiBone12/17/2025Boost Price Target$19.51$27.00Buy$0.0000.00% ROITNDMTandem Diabetes Care12/17/2025Set Price Target$22.60$35.00Buy$0.0000.00% ROIPENPenumbra12/17/2025Boost Price Target$308.27$359.00Buy$0.0000.00% ROIEWEdwards Lifesciences12/17/2025Set Price Target$85.56$87.00Hold$0.0000.00% ROIBSXBoston Scientific12/17/2025Lower Price Target$95.02$131.00Buy$0.0000.00% ROIAORTArtivion12/17/2025Reiterated Rating$46.04$51.00Buy$0.0000.00% ROICBLLCeriBell12/17/2025Boost Price Target$21.74$30.00Buy$0.0000.00% ROITMDXTransMedics Group12/17/2025Boost Price Target$122.75$148.00Buy$0.0000.00% ROITLSITriSalus Life Sciences12/17/2025Boost Price Target$7.31$12.00Buy$0.0000.00% ROIPODDInsulet12/17/2025Boost Price Target$288.73$450.00Buy$0.0000.00% ROIEWEdwards Lifesciences12/5/2025Set Price Target$85.72$89.00$0.0000.00% ROIBuy this stock tomorrow (Ad)Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership with Nvidia - one he believes positions it ahead of Tesla in the autonomous vehicle race. With a market-moving announcement expected on July 31st, Chaikin is urging investors to swap overpriced AI stocks for this under-the-radar name before markets open. He's also releasing a free Hotlist and Hitlist of buy and sell ideas for the second half of 2026.Get the ticker symbol and full details at no charge todayEWEdwards Lifesciences12/5/2025Reiterated Rating$85.72$89.00Hold$0.0000.00% ROIPODDInsulet11/24/2025Boost Price Target$331.17$432.00Buy$0.0000.00% ROIHTFLHeartflow11/13/2025Boost Price Target$31.66$40.00Buy$0.0000.00% ROIAORTArtivion11/7/2025Boost Price Target$44.82$51.00Buy$0.0000.00% ROIPODDInsulet11/7/2025Boost Price Target$319.82$428.00Buy$0.0000.00% ROIPENPenumbra11/6/2025Boost Price Target$265.79$355.00Buy$0.0000.00% ROICVRXCVRx11/6/2025Boost Price Target$10.00$11.00Buy$0.0000.00% ROIEWEdwards Lifesciences11/3/2025Reiterated Rating$82.48$84.00Hold$0.0000.00% ROIDXCMDexCom10/31/2025Set Price Target$68.20$99.00Buy$0.0000.00% ROIIRTCiRhythm Technologies10/31/2025Boost Price Target$187.30$212.00Buy$0.0000.00% ROIATRCAtriCure10/30/2025Boost Price Target$35.44$64.00Buy$0.0000.00% ROITMDXTransMedics Group10/30/2025Boost Price Target$134.32$147.00Buy$0.0000.00% ROIBSXBoston Scientific10/23/2025Reiterated Rating$103.66$132.00Buy$0.0000.00% ROITMDXTransMedics Group10/14/2025Reiterated Rating$111.38$142.00Buy$0.0000.00% ROIBSXBoston Scientific10/1/2025Boost Price Target$97.55$132.00Buy$0.0000.00% ROIPODDInsulet9/29/2025Boost Price Target$318.00$399.00Buy$0.0000.00% ROIIRTCiRhythm Technologies9/29/2025Boost Price Target$170.81$193.00Buy$0.0000.00% ROIAORTArtivion9/29/2025Boost Price Target$40.98$50.00Buy$0.0000.00% ROITNDMTandem Diabetes Care9/29/2025Reiterated Rating$11.85$24.00Buy$0.0000.00% ROIDXCMDexCom9/29/2025Reiterated Rating$66.14$106.00Buy$0.0000.00% ROIHTFLHeartflow9/22/2025Boost Price Target$32.88$39.00Buy$0.0000.00% ROIHTFLHeartflow9/2/2025Initiated Coverage$31.50$35.00Buy$0.0000.00% ROIPODDInsulet8/8/2025Boost Price Target$307.10$353.00Buy$0.0000.00% ROIAORTArtivion8/8/2025Boost Price Target$40.89$41.00Buy$0.0000.00% ROITNDMTandem Diabetes Care8/7/2025Set Price Target$11.18$24.00Buy$0.0000.00% ROISTIMNeuronetics8/6/2025Lower Price Target$4.21$7.00Buy$0.0000.00% ROIDXCMDexCom8/1/2025Reiterated Rating$80.05$106.00Buy$00.0000.00% ROIIRTCiRhythm Technologies8/1/2025Boost Price Target$165.04$170.00Buy$000.0000.00% ROIEWEdwards Lifesciences7/25/2025Boost Price Target$79.13$81.00Hold$00.0000.00% ROIGMEDGlobus Medical7/22/2025Lower Price Target$53.16$90.00Buy$00.0000.00% ROIANGOAngioDynamics7/16/2025Boost Price Target$8.65$17.00Buy$00.0000.00% ROITMDXTransMedics Group7/15/2025Boost Price Target$116.94$142.00Buy$00.0000.00% ROIAORTArtivion6/17/2025Initiated Coverage$28.68$35.00Buy$00.0000.00% ROIZBHZimmer Biomet5/12/2025Lower Price Target$98.77$101.00Hold$00.0000.00% ROIIRTCiRhythm Technologies5/2/2025Lower Price Target$131.55$139.00Buy$000.0000.00% ROIDXCMDexCom5/2/2025Boost Price Target$81.75$106.00Buy$00.0000.00% ROITNDMTandem Diabetes Care5/1/2025Boost Price Target$19.98$59.00Buy$00.0000.00% ROIEWEdwards Lifesciences4/25/2025Boost Price Target$75.15$75.00Hold$00.0000.00% ROICVRXCVRx4/8/2025Lower Price Target$11.54$18.00Buy$0.0000.00% ROIATRCAtriCure3/28/2025Lower Price Target$34.37$52.00Buy$00.0000.00% ROITLSITriSalus Life Sciences3/28/2025Reiterated Rating$5.44$11.00Buy$0.0000.00% ROITMDXTransMedics Group3/11/2025Reiterated Rating$67.54$104.00Buy$000.0000.00% ROISTIMNeuronetics3/5/2025Boost Price Target$5.42$8.00Buy$0.0000.00% ROICBLLCeriBell2/26/2025Reiterated Rating$25.90$33.00Buy$00.0000.00% ROITNDMTandem Diabetes Care2/26/2025Reiterated Rating$33.83$63.00Buy$00.0000.00% ROIDXCMDexCom2/14/2025Boost Price Target$84.09$103.00Buy$00.0000.00% ROIEWEdwards Lifesciences2/13/2025Boost Price Target$75.83$71.00Hold$00.0000.00% ROIATRCAtriCure2/13/2025Boost Price Target$42.36$66.00Buy$00.0000.00% ROICVRXCVRx2/5/2025Boost Price Target$16.25$23.00Buy$0.0000.00% ROIGMEDGlobus Medical1/10/2025Boost Price Target$88.42$101.00Buy$00.0000.00% ROIThe REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is. Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
